RedHill Biopharma (Israel) Financial Diagnostics

RDHL -- Israel Stock  

ILS 308.40  19.80  6.86%

RedHill Biopharma Ltd diagnostics interface makes it easy to digest most current publicly released information about RedHill Biopharma as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis RedHill Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

RedHill Biopharma Note

The company recorded loss per share of 0.25. RedHill Biopharma Ltd had not issued any dividends in recent years. RedHill Biopharma Ltd., a specialty biopharmaceutical company, focuses on the development and commercialization of late clinical-stage drugs for the treatment of gastrointestinal diseases. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 74 people. To find out more about REDHILL BIOPHARMA contact Ori Shilo at 972 3 541 3131 or learn more at

RedHill Biopharma Alerts

RedHill Biopharma appears to be very risky and stock price may revert if volatility continues
The company reported revenue of 6.45 M. Net Loss for the year was (46.88 M) with profit before overhead, payroll, taxes, and interest of 1.88 M.
REDHILL BIOPHARMA has accumulated about 36.35 M in cash with (43.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Latest headline from RedHill Biopharma Ltd. s Volatility Moves the Target Weight to 0.02130 With 13.26930 Sales Growth

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 755.36 M.

Management Efficiency

RedHill Biopharma Ltd has return on total asset (ROA) of (54.98) % which means that it has lost $54.98 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (98.45) % meaning that it generated substantial loss on money invested by shareholders.

Technical Drivers

RedHill Biopharma Ltd holds Coefficient Of Variation of 582.09, Semi Deviation of 3.37 and Risk Adjusted Performance of 0.1945. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of RedHill Biopharma as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for RedHill Biopharma which can be compared to its competitors. Please check RedHill Biopharma Downside Deviation, Standard Deviation, Information Ratio, as well as the relationship between Coefficient Of Variation and Variance to decide if RedHill Biopharma is priced some-what accurately providing market reflects its current price of 308.4 per share.

RedHill Biopharma Price Movement Analysis

Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
Execute Study
The output start index for this execution was eleven with a total number of output elements of six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. RedHill Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for RedHill Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

RedHill Biopharma Technical and Predictive Indicators

RedHill Biopharma Forecast Models

Did you try this?

Run Portfolio Suggestion Now


Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Portfolio Suggestion

Also Currentnly Active

Purchased over 100 shares of
few hours ago
Traded for 278.27
Purchased over 10K shares of
few hours ago
Traded for 79.88
Sold over 100 shares of
few hours ago
Traded for 187.94
Additionally take a look at Your Equity Center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.